News

Pharmabiz30m
Novartis announces top-line results from phase III GCAptAIN study of Cosentyx in giant cell arteritis
Novartis announced top-line results from the phase III GCAptAIN study evaluating Cosentyx (secukinumab) in adults with newly diagnosed or relapsing giant cell arteritis (GCA). In the study, Cosentyx ...
Pharmabiz1h
Lifesciences industry adopts a wait-and-watch approach amid US tariff uncertainty: Aditya Sharma
Lifesciences industry adopts a wait-and-watch approach amid US tariff uncertainty: Aditya Sharma: Nandita Vijayasimha, Friday, July 4, 2025, 08:00 Hrs [IST] Lifesciences industry ...
Pharmabiz1h
India and Myanmar in talks to fast-track approval for pharma products in Myanmar
India and Myanmar in talks to fast-track approval for pharma products in Myanmar: Shardul Nautiyal, Mumbai Friday, July 4, 2025, 08:00 Hrs [IST] In a major development to boost ph ...
Pharmabiz1h
Pharma industry eyes secure graphics & continuous data protection amid QR code counterfeit surge
Pharma industry eyes secure graphics & continuous data protection amid QR code counterfeit surge: Nandita Vijayasimha, Bengaluru Friday, July 4, 2025, 08:00 Hrs [IST] The pharmace ...
Pharmabiz1h
Pharmac South 2025 to kick off today at Chennai Trade Centre
The 10th edition of Pharmac South, the high-powered pharmaceutical and nutraceutical trade show, will open its doors today at the Chennai Trade Centre at Nandambakkam. The two-day event, running ...
Pharmabiz1h
Govt to amend Rules to move preparations with higher alcoholic content to Schedule H1
Govt to amend Rules to move preparations with higher alcoholic content to Schedule H1: Gireesh Babu, New Delhi Friday, July 4, 2025, 08:00 Hrs [IST] The Drugs Consultative Committ ...
Pharmabiz15h
Ensem Therapeutics doses first patient in phase 1/2 study of ETX-636, a novel allosteric pan-mutant-selective PI3Ka inhibitor and degrader
Ensem Therapeutics doses first patient in phase 1/2 study of ETX-636, a novel allosteric pan-mutant-selective PI3Ka inhibitor and degrader: Waltham, Massachusetts Thursday, July 3 ...
Pharmabiz16h
CBI searches premises of PCI president Montu Kumar Patel, say reports
CBI searches premises of PCI president Montu Kumar Patel, say reports: Our Bureau, New Delhi Thursday, July 3, 2025, 17:25 Hrs [IST] The Central Bureau of Investigation (CBI) has ...
Pharmabiz16h
KSPC launches maiden virtual simulation-based pharma manufacturing training programme
KSPC launches maiden virtual simulation-based pharma manufacturing training programme: Our Bureau, Bengaluru Thursday, July 3 ...
Pharmabiz16h
Onward Medical submits two major regulatory applications for its ARC-EX system; seeking clearance to expand its indication for home use
Onward Medical submits two major regulatory applications for its ARC-EX system; seeking clearance to expand its indication for home use: Eindhoven, the Netherlands Thursday, July ...
Pharmabiz17h
Industry leaders support Covid-19 vaccines following Karnataka CM's remarks
Industry leaders support Covid-19 vaccines following Karnataka CM's remarks: Our Bureau, New Delhi Thursday, July 3, 2025, 16:30 Hrs [IST] After the Central government, the indust ...
Pharmabiz17h
Senzime’s neuromuscular monitoring solution, TetraGraph system receives US patent
Senzime’s neuromuscular monitoring solution, TetraGraph system receives US patent: Uppsala, Sweden Thursday, July 3, 2025, 16:00 Hrs [IST] Uppsala-headquartered Senzime, a leadi ...